CalciMedica, Inc.CALCNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P32
Within normal range
vs 5Y Ago
-1.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.32% |
| Q3 2025 | -4.96% |
| Q2 2025 | -4.07% |
| Q1 2025 | 10.26% |
| Q4 2024 | 8.04% |
| Q3 2024 | -14.70% |
| Q2 2024 | 41.20% |
| Q1 2024 | 5.82% |
| Q4 2023 | 0.36% |
| Q3 2023 | -27.32% |
| Q2 2023 | -41.24% |
| Q1 2023 | 237.72% |
| Q4 2022 | 54.50% |
| Q3 2022 | -44.93% |
| Q2 2022 | -22.77% |
| Q1 2022 | 6.17% |
| Q4 2021 | -31.48% |
| Q3 2021 | -3.48% |
| Q2 2021 | -35.39% |
| Q1 2021 | 17.49% |
| Q4 2020 | 15.37% |
| Q3 2020 | 2.70% |
| Q2 2020 | -23.88% |
| Q1 2020 | -24.03% |
| Q4 2019 | -4.68% |
| Q3 2019 | 0.00% |